全球支架移植物用球囊导管市场规模（按产品、应用、地区、范围和预测）

支架移植物球囊导管的市场规模及预测

近年来，支架移植物用球囊导管的市场规模一直以中等速度成长，成长率显着，预计 2024 年至 2031 年间将大幅成长。

支架移植物球囊导管的全球市场驱动因子

支架移植物球囊导管市场的市场推动因素受到多种因素的影响。

血管疾病盛行率不断上升

随着血管疾病（包括週边动脉疾病、主动脉瘤和其他心血管疾病）的发生率不断上升，对支架移植物球囊导管的需求也随之增加。此类设备对于有效治疗这些疾病是必要的。

老年人口不断增加：

随着世界人口老化，人们更容易受到血管疾病及其影响，增加了对球囊导管和支架移植等医疗程序的需求。这些设备通常是老年人成功进行血管治疗所必需的。

医疗科技的进步：

由于医疗技术的不断进步，包括开发采用更好的材料、更卓越的设计和功能的先进支架移植物球囊导管，该市场正在不断增长。这些发展使得程序更加安全、有效率和简单。

越来越多的患者和医疗保健专业人员选择微创手术，因为它具有恢復更快、併发症更少、住院时间更短的优点。用于支架移植的球囊导管对于这些微创血管治疗至关重要。

提高对血管疾病的认识与辨识：

随着人们对疾病认识的提高和诊断工具的进步，早期发现和治疗血管疾病成为可能。因此，接受早期诊断和早期治疗的患者数量将会增加，从而增加对支架移植物球囊导管的需求。

影像与诊断技术的发展：

CT、MRI 和超音波等影像技术的进步使得支架移植物球囊导管的准确诊断和精确放置成为可能。改进的诊断成像将改善治疗结果并鼓励使用这些设备。

优惠的付款政策：

如果国家和私人保险公司对支架移植手术等血管介入治疗提供优惠的支付政策，那么会有更多的患者选择支架移植手术等血管介入治疗。这促使支架移植手术中使用的球囊导管的需求增加。

增加医疗支出：

医疗保健支出的增加，尤其是在新兴国家，正在改善获得尖端医疗程序和设备的机会。随着医疗服务和基础设施支出的增加，支架移植物球囊导管市场正在扩大。

血管手术数量不断增加：

随着血管问题变得越来越普遍，对支架移植球囊导管的需求也日益增加。支架移植物用的球囊导管是达到良好手术效果的重要工具。

限制全球支架移植物球囊导管市场的因素

有几个因素可能会对支架移植物球囊导管市场造成限制和课题。

昂贵的手术：

与传统手术相比，使用球囊导管进行支架移植的微创手术费用昂贵。高昂的手术费用会限制患者的手术治疗，特别是在保险覆盖和医疗资源有限的地区。

兑换难度：

微创手术的报销指南可能因地区和医疗保健系统而异。由于不确定性以及支付率和承保范围指南的变化，支架移植物球囊导管的引入可能会对医疗保健提供者产生影响。

监理障碍：

美国 FDA 和欧洲 CE 标誌等医疗机构对支架移植物用球囊导管制定了严格的规定。获得监管部门的批准成本高昂且耗时，这可能会延迟新产品的上市。

临床资料需求

儘管支架移植物球囊导管的安全性和有效性已得到证实，但监管机构和医疗保健提供者经常需要可靠的临床数据来支持这一说法。临床试验可能需要大量时间和资源来产生足够的数据。

技术复杂性：

製造一种称为支架移植物球囊导管的复杂医疗设备需要先进的工程和製造方法。以监管的方式开发和製造这些医疗设备非常困难且成本高昂。

产品召回与安全问题：

与支架移植物球囊导管有关的不良事件、产品召回和安全问题可能会削弱消费者信心并引起监管机构的注意。为了使产品被市场接受和发展，必须保持产品的品质和安全。

与替代疗法竞争：

球囊导管支架移植的替代方案包括传统开放性手术、药物治疗和其他微创疗法。医疗保健专业人员可以根据临床建议、患者俱体标准和财务限制选择替代疗法。

创新疗法的报销限制：

最初，付款人可能无法完全偿还创新球囊导管疗法的费用。这可能会阻止医疗保健提供者在支付指南最终确定之前采用新方法或设备。

教育与训练要求

在微创手术中使用球囊导管进行支架移植物需要特殊的知识和训练。缺乏技术熟练的医生和培训项目，尤其是在贫困地区和农村地区，可能会阻碍这些程序的采用。

全球供应链中断：

贸易限制、自然灾害和地缘政治衝突等事件都会影响医疗器材的全球供应链，包括支架移植的球囊导管。供应链中断可能导致成本增加和产品交付延迟。

目录

第 1 章全球支架移植物球囊导管市场：简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章 支架移植物球囊导管的全球市场展望

• 概述
• 市场动态
• 促进因素
• 阻碍因素
• 机会
• 波特五力模型
• 价值链分析

第 5 章 全球支架移植物球囊导管市场（依产品）

• 聚氨酯
• 尼龙
• 其他

第6章 全球支架移植物球囊导管市场（依应用）

• 医院
• 心臟中心诊所
• 门诊手术中心 (ASC)

第 7 章全球支架移植物球囊导管市场（按地区）

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 德国
• 英国
• 法国
• 其他欧洲国家 亚太地区
• 中国
• 日本
• 印度
• 其他亚太地区
• 世界其他地区
• 拉丁美洲
• 中东和非洲

第 8 章 支架移植物球囊导管的全球市场：竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第9章 公司简介

• Medtronic
• B. Braun
• Jotech
• Cordis
• Terumo
• Boston Scientific
• Cook Medical
• Abbott Laboratories
• MicroPort Scientific
• Cardionovum
• Hexacath
• Meril Life Sciences

第 10 章附录

• 相关报告

Stent Graft Balloon Catheter Market Size And Forecast

Stent Graft Balloon Catheter Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2024 to 2031.

Global Stent Graft Balloon Catheter Market Drivers

The market drivers for the Stent Graft Balloon Catheter Market can be influenced by various factors. These may include:

Growing Prevalence of Vascular disorders:

The need for stent graft balloon catheters is driven by the rising prevalence of vascular disorders, which include peripheral artery disease, aortic aneurysms, and other cardiovascular conditions. Effective treatment of these illnesses requires these equipment.

Growing Ageing Population:

As people age globally, they become more vulnerable to vascular illnesses and their consequences, which increases the need for medical procedures like balloon catheter stent grafts. These devices are frequently necessary for the older population to receive successful vascular therapies.

Medical Technology Advancements:

The market is growing due to ongoing improvements in medical technology, such as the creation of sophisticated stent graft balloon catheters with better materials, better designs, and increased functionality. Procedures are now safer, more efficient, and simpler to carry out thanks to these developments.

A increasing number of patients and healthcare professionals are choosing minimally invasive procedures because of its advantages, which include quicker recovery times, less problems, and shorter hospital stays. Balloon catheters for stent grafts are essential to these minimally invasive vascular treatments.

Growing Recognition and Identification of Vascular Illnesses:

Early detection and treatment of vascular disorders are made possible by greater awareness of the condition and advancements in diagnostic tools. As a result, more patients receive early diagnosis and treatment, which increases demand for stent graft balloon catheters.

Technological Developments in Imaging and Diagnostics:

Accurate diagnosis and precise implantation of stent graft balloon catheters are made possible by advancements in imaging technologies, including CT, MRI, and ultrasound. Improved imaging encourages greater therapy results and propels the use of these gadgets.

Advantageous payment Policies:

More patients choose vascular interventions, such as stent graft operations, when government and commercial insurance companies offer advantageous payment policies for these procedures. This increases the need for balloon catheters used in stent grafting.

Growing Healthcare Expenditure:

Access to cutting-edge medical procedures and equipment is improved by growing healthcare spending, especially in emerging nations. The market for stent graft balloon catheters is growing as a result of increased expenditure in healthcare services and infrastructure.

Growing Number of Vascular Surgeries:

As vascular problems become more common, there is a growing need for stent graft balloon catheters, which is being driven by the rising number of vascular surgeries conducted globally. These tools are essential for good surgical results.

Global Stent Graft Balloon Catheter Market Restraints

Several factors can act as restraints or challenges for the Stent Graft Balloon Catheter Market. These may include:

Expensive Procedures:

When compared to conventional surgeries, minimally invasive procedures utilising balloon catheters for stent grafts might be costly. Patient access may be restricted by the high cost of operations, particularly in areas with inadequate insurance coverage and healthcare resources.

Difficulties with Reimbursement:

Different geographic areas and healthcare systems may have different reimbursement guidelines for minimally invasive procedures. Healthcare practitioners' adoption of stent graft balloon catheters may be impacted by uncertainty or modifications to payment rates and coverage guidelines.

Regulatory Obstacles:

Health authorities like the FDA in the US and the CE marking procedure in Europe have strict regulations governing stent graft balloon catheters. Getting regulatory clearances may be expensive and time-consuming, which delays the introduction of new items onto the market.

Clinical data Requirements:

Stent graft balloon catheter safety and efficacy have been shown, and regulatory bodies and healthcare providers frequently need solid clinical data supporting this claim. Clinical studies might take a lot of time and resources to complete in order to produce enough data.

Technological Complexity:

Advanced engineering and manufacturing methods are needed to produce the sophisticated medical devices known as stent graft balloon catheters. It can be difficult and expensive to develop and manufacture these devices in compliance with regulatory regulations.

Product Recalls and Safety Concerns:

Stent graft balloon catheter-related adverse events, product recalls, and safety concerns can undermine customer trust and draw regulatory attention. For a product to be accepted and thrive in the market, quality and safety must be maintained.

Competition from Alternative Therapies:

Conventional open surgery, medicine, and other minimally invasive methods are some of the alternatives to stent graft balloon catheters. Healthcare professionals may select alternative therapies in accordance with clinical recommendations, patient-specific criteria, and financial constraints.

Limited Reimbursement for Innovative treatments:

At first, healthcare payers might not fully reimburse innovative treatments employing stent graft balloon catheters. This may discourage medical professionals from implementing novel methods and equipment until such time as payment guidelines are finalised.

Requirements for Education and Training:

Using stent graft balloon catheters for minimally invasive operations calls for specific knowledge and training. Adoption of these procedures may be hampered by limited access to skilled physicians and training programmes, especially in underprivileged or rural locations.

Disruptions to the Global Supply Chain:

Events like trade restrictions, natural catastrophes, and geopolitical conflicts can all have an impact on the global supply chain for medical equipment, including stent graft balloon catheters. Disruptions to the supply chain may result in higher expenses and product availability delays.

Segmentation Analysis

The Global Stent Graft Balloon Catheter Market is Segmented on the basis of Product Type, Application, End-User, and Geography.

Stent Graft Balloon Catheter Market, By Product Type

• Non-Compliant Balloon Catheters:
• Balloon catheters with a rigid structure designed for high-pressure dilatation of stent grafts.
• Compliant Balloon Catheters:
• Balloon catheters with a flexible structure designed to conform to the shape of the vessel during dilatation.
• Semi-Compliant Balloon Catheters:
• Balloon catheters with intermediate properties between non-compliant and compliant balloons, offering a balance between rigidity and flexibility.

Stent Graft Balloon Catheter Market, By Application

• Endovascular Aneurysm Repair (EVAR):
• Treatment of abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA) using stent grafts delivered via balloon catheters.
• Thoracic Endovascular Aneurysm Repair (TEVAR):
• Treatment specifically targeting thoracic aortic aneurysms.
• Peripheral Vascular Interventions:
• Treatment of peripheral artery diseases (PAD) and other vascular conditions using stent grafts delivered via balloon catheters.
• Other Applications:
• Including treatment of arteriovenous (AV) fistulas, venous stenosis, and other vascular conditions.

Stent Graft Balloon Catheter Market, By

• End-User
• Hospitals:
• Major healthcare facilities where endovascular procedures are commonly performed.
• Ambulatory Surgical Centers (ASCs):
• Outpatient centers specializing in minimally invasive procedures, including endovascular interventions.
• Specialty Clinics:
• Clinics focusing on vascular health and interventions.
• Others:
• Including academic and research institutions involved in clinical trials and studies related to endovascular treatments.

Stent Graft Balloon Catheter Market, By Geography

• North America:
• Includes the United States and Canada, characterized by advanced healthcare infrastructure and high adoption of endovascular procedures.
• Europe:
• Includes countries such as Germany, the UK, France, Italy, and Spain, with strong healthcare systems and a growing prevalence of vascular diseases.
• Asia-Pacific:
• Includes China, Japan, India, South Korea, and Australia, where increasing healthcare investments and a rising aging population drive market growth.
• Latin America:
• Includes Brazil, Mexico, and other countries in Central and South America, with emerging healthcare markets.
• Middle East and Africa:
• Includes countries such as Saudi Arabia, UAE, South Africa, and others, where there is growing investment in healthcare infrastructure and a rising prevalence of cardiovascular diseases.

Key Players

• The "Global Stent Graft Balloon Catheter Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are
• Jotech, Terumo, Boston Scientific, MicroPort Scientific, Cardionovum, Hexacath, Meril Life Sciences, Medtronic Plc, Cordis Corporation, B. Braun Melsungen AG, Cook Medical Inc, Terumo Corporation, Abbott Laboratories and Boston Scientific Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1. Introduction of Global Stent Graft Balloon Catheter Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Stent Graft Balloon Catheter Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Stent Graft Balloon Catheter Market, By Product

• Polyurethane
• Nylon
• Others

6. Global Stent Graft Balloon Catheter Market, By Application

• Hospitals
• Cardiac Center & Clinics
• Ambulatory Surgical Centers (ASCs)

7. Global Stent Graft Balloon Catheter Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Stent Graft Balloon Catheter Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• Medtronic
• B. Braun
• Jotech
• Cordis
• Terumo
• Boston Scientific
• Cook Medical
• Abbott Laboratories
• MicroPort Scientific
• Cardionovum
• Hexacath
• Meril Life Sciences

10. Appendix

• Related Reports